71:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
Chronic obstructive pulmonary disease:@0.076190:0.099847:0.713206:0.099847:0.713206:0.063183:0.076190:0.063183:0.026206:0.020159:0.010751:0.021503:0.020159:0.008063:0.021503:0.009407:0.021503:0.022175:0.014783:0.010079:0.010751:0.020159:0.021503:0.010079:0.008063:0.018815:0.021503:0.009407:0.022175:0.020159:0.008063:0.031582:0.021503:0.020159:0.022175:0.010751:0.019487:0.009407:0.022175:0.008063:0.014783:0.021503:0.022175:0.014783:0.021503
A Peter:@0.076190:0.169924:0.134651:0.169924:0.134651:0.151592:0.076190:0.151592:0.012431:0.004704:0.009407:0.010751:0.005040:0.010751:0.005376
MBBCh (Wits), DA(sA), FCp(sA) Cert pulm.:@0.076190:0.181956:0.346290:0.181956:0.346290:0.167927:0.076190:0.167927:0.012351:0.007714:0.007714:0.010926:0.008198:0.003723:0.004959:0.012902:0.002688:0.004556:0.005214:0.004959:0.003723:0.003723:0.009999:0.009945:0.004959:0.006693:0.009945:0.004959:0.003723:0.003723:0.006518:0.010926:0.007956:0.004959:0.006693:0.009945:0.004959:0.003723:0.010926:0.008735:0.004045:0.004556:0.003723:0.007956:0.008171:0.002688:0.012606:0.003723
Specialist Physician and Subspecialist Pulmonologist;:@0.076190:0.199906:0.414776:0.199906:0.414776:0.185877:0.076190:0.185877:0.006693:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.007956:0.008198:0.007203:0.005214:0.002688:0.008695:0.002688:0.009179:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.006693:0.008171:0.009165:0.005214:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.007956:0.008171:0.002688:0.012606:0.008803:0.008198:0.008803:0.002688:0.008803:0.009045:0.002688:0.005214:0.004556:0.003723
Full-time Principal Specialist, Department of Medicine,:@0.076190:0.212724:0.425057:0.212724:0.425057:0.198695:0.076190:0.198695:0.006518:0.008171:0.002688:0.002688:0.004462:0.004556:0.002688:0.012606:0.008735:0.003723:0.007956:0.004045:0.002688:0.008198:0.008695:0.002688:0.009165:0.009179:0.002688:0.003723:0.006693:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.003723:0.009999:0.008735:0.009165:0.009179:0.004045:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723:0.008803:0.004220:0.003723:0.012351:0.008735:0.009206:0.002688:0.008695:0.002688:0.008198:0.008735:0.003723
Chris Hani Baragwanath Academic Hospital, Johannesburg:@0.076190:0.225542:0.463130:0.225542:0.463130:0.211513:0.076190:0.211513:0.010926:0.008198:0.004045:0.002688:0.005214:0.003723:0.009179:0.009179:0.008198:0.002688:0.003723:0.007714:0.009179:0.004045:0.009179:0.009045:0.011168:0.009179:0.008198:0.009179:0.004556:0.008198:0.003723:0.009945:0.008695:0.009179:0.009206:0.008735:0.012606:0.002688:0.008695:0.003723:0.009179:0.008803:0.005214:0.009165:0.002688:0.004556:0.009179:0.002688:0.003723:0.003723:0.006478:0.008803:0.008198:0.009179:0.008198:0.008198:0.008735:0.005214:0.009165:0.008171:0.004045:0.009045
Chronic obstructive pulmonary disease (COpD) is esti-:@0.076190:0.255439:0.480957:0.255439:0.480957:0.239657:0.076190:0.239657:0.012292:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.006199:0.009903:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.008376:0.009827:0.006199:0.010311:0.009192:0.003024:0.014182:0.009903:0.009223:0.010326:0.004551:0.008104:0.006199:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.006214:0.005579:0.012292:0.013138:0.008950:0.011249:0.005579:0.006214:0.003024:0.005866:0.006214:0.009827:0.005866:0.005125:0.003024:0.005020
mated to be the third most common cause of death :@0.076190:0.269548:0.485160:0.269548:0.485160:0.253765:0.076190:0.253765:0.014182:0.010326:0.005125:0.009827:0.010357:0.006290:0.005125:0.009903:0.006290:0.010311:0.009827:0.006290:0.005125:0.009223:0.009827:0.006290:0.005125:0.009223:0.003024:0.004551:0.010357:0.006290:0.014182:0.009903:0.005866:0.005125:0.006290:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.006274:0.009782:0.010326:0.009192:0.005866:0.009827:0.006290:0.009903:0.004747:0.006290:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188
by 2020.:@0.076190:0.283657:0.136818:0.283657:0.136818:0.267874:0.076190:0.267874:0.010311:0.008104:0.004521:0.008376:0.008376:0.008376:0.008376:0.004188
1:@0.136825:0.278347:0.141683:0.278347:0.141683:0.269193:0.136825:0.269193:0.004858
 COPD is defined as a “common, preventable :@0.141685:0.283646:0.485175:0.283646:0.485175:0.267863:0.141685:0.267863:0.004521:0.012292:0.013138:0.008950:0.011249:0.004521:0.003024:0.005866:0.004521:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.004521:0.010326:0.005866:0.004521:0.010326:0.004521:0.007590:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188:0.004505:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.010326:0.010311:0.003024:0.009827:0.004188
and treatable disease that is characterised by persistent :@0.076190:0.297754:0.485144:0.297754:0.485144:0.281972:0.076190:0.281972:0.010326:0.009223:0.010357:0.003266:0.005125:0.004551:0.009827:0.010326:0.005125:0.010326:0.010311:0.003024:0.009827:0.003266:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.003281:0.005125:0.009223:0.010326:0.005125:0.003266:0.003024:0.005866:0.003281:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.003266:0.010311:0.008104:0.003281:0.010311:0.009827:0.004551:0.005866:0.003024:0.005866:0.005125:0.009827:0.009223:0.005125:0.004188
respiratory symptoms and airflow limitation that is due to :@0.076190:0.311863:0.485144:0.311863:0.485144:0.296080:0.076190:0.296080:0.004551:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.003538:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.003553:0.010326:0.009223:0.010357:0.003553:0.010326:0.003024:0.004551:0.003666:0.003666:0.009903:0.012564:0.003553:0.003024:0.003024:0.014182:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.003553:0.005125:0.009223:0.010326:0.005125:0.003553:0.003024:0.005866:0.003553:0.010357:0.009192:0.009827:0.003553:0.005125:0.009903:0.004188
airway and/or alveolar abnormalities usually caused by :@0.076190:0.325971:0.485114:0.325971:0.485114:0.310189:0.076190:0.310189:0.010326:0.003024:0.004551:0.012564:0.010326:0.008104:0.004052:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004037:0.010326:0.003024:0.008376:0.009827:0.009903:0.003024:0.010326:0.004551:0.004052:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.004052:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004067:0.009782:0.010326:0.009192:0.005866:0.009827:0.010357:0.004052:0.010311:0.008104:0.004188
significant exposure to noxious particles or gases”.:@0.076190:0.340080:0.440437:0.340080:0.440437:0.324297:0.076190:0.324297:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004188:0.009827:0.007257:0.010311:0.009903:0.005866:0.009192:0.004551:0.009827:0.004188:0.005125:0.009903:0.004188:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.004188:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005866:0.004188:0.009903:0.004551:0.004188:0.010175:0.010326:0.005866:0.009827:0.005866:0.007318:0.004188
1:@0.440406:0.334760:0.445264:0.334760:0.445264:0.325606:0.440406:0.325606:0.004858
The prevalence and burden of COpD are related to :@0.090476:0.354161:0.485144:0.354161:0.485144:0.338379:0.090476:0.338379:0.006441:0.009223:0.009827:0.005428:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.005443:0.010326:0.009223:0.010357:0.005443:0.010311:0.009192:0.004551:0.010357:0.009827:0.009223:0.005428:0.009903:0.004747:0.005428:0.012292:0.013138:0.008950:0.011249:0.005443:0.010326:0.004551:0.009827:0.005443:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.005443:0.005125:0.009903:0.004188
the  interplay between  host  factors  together  with  the :@0.076189:0.368270:0.485128:0.368270:0.485128:0.352487:0.076189:0.352487:0.005125:0.009223:0.009827:0.004188:0.003251:0.003024:0.009223:0.005125:0.009827:0.004551:0.010311:0.003024:0.010326:0.008104:0.007454:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.004188:0.003251:0.009223:0.009903:0.005866:0.005125:0.004188:0.003251:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.003251:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.004188:0.003235:0.012564:0.003024:0.005125:0.009223:0.004188:0.003251:0.005125:0.009223:0.009827:0.004188
noxious particles and gases that are inhaled. The most :@0.076189:0.382378:0.485144:0.382378:0.485144:0.366596:0.076189:0.366596:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.005292:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005866:0.005292:0.010326:0.009223:0.010357:0.005292:0.010175:0.010326:0.005866:0.009827:0.005866:0.005292:0.005125:0.009223:0.010326:0.005125:0.005292:0.010326:0.004551:0.009827:0.005292:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.004188:0.005292:0.006441:0.009223:0.009827:0.005292:0.014182:0.009903:0.005866:0.005125:0.004188
common  noxious gas-particle mixture  inhaled is to-:@0.076189:0.396487:0.480940:0.396487:0.480940:0.380704:0.076189:0.380704:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188:0.005594:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.009797:0.010175:0.010326:0.005866:0.005020:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.009797:0.014182:0.003024:0.007257:0.005125:0.009192:0.004551:0.009827:0.004188:0.005594:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.009797:0.003024:0.005866:0.009797:0.005125:0.009903:0.005020
bacco smoke, the primary cause of COpD. However, :@0.076189:0.410596:0.485159:0.410596:0.485159:0.394813:0.076189:0.394813:0.010311:0.010326:0.009782:0.009782:0.009903:0.006410:0.005866:0.014182:0.009903:0.007590:0.009827:0.004188:0.006410:0.005125:0.009223:0.009827:0.006410:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.006410:0.009782:0.010326:0.009192:0.005866:0.009827:0.006410:0.009903:0.004747:0.006410:0.012292:0.013138:0.008950:0.011249:0.004188:0.006410:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188
approximately 20% of smokers develop COpD and thus :@0.076189:0.424704:0.485128:0.424704:0.485128:0.408921:0.076189:0.408921:0.010326:0.010311:0.010311:0.004551:0.009903:0.007257:0.003024:0.014182:0.010326:0.005125:0.009827:0.003024:0.008104:0.004430:0.008376:0.008376:0.011717:0.004430:0.009903:0.004747:0.004430:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.005866:0.004430:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.004430:0.012292:0.013138:0.008950:0.011249:0.004430:0.010326:0.009223:0.010357:0.004430:0.005125:0.009223:0.009192:0.005866:0.004188
host factors and an individual’s  genetic response to :@0.076189:0.438813:0.485174:0.438813:0.485174:0.423030:0.076189:0.423030:0.009223:0.009903:0.005866:0.005125:0.008058:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.008058:0.010326:0.009223:0.010357:0.008058:0.010326:0.009223:0.008058:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009207:0.010326:0.003024:0.005307:0.005866:0.004188:0.003886:0.010175:0.009827:0.009223:0.009827:0.005125:0.003024:0.009782:0.008058:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.008058:0.005125:0.009903:0.004188
noxious stimuli play a role in disease development.:@0.076189:0.452921:0.444216:0.452921:0.444216:0.437138:0.076189:0.437138:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.004188:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.003024:0.004188:0.010311:0.003024:0.010326:0.008104:0.004188:0.010326:0.004188:0.004551:0.009903:0.003024:0.009827:0.004188:0.003024:0.009223:0.004188:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.004188
1:@0.444215:0.447585:0.449073:0.447585:0.449073:0.438431:0.444215:0.438431:0.004858
Taking into consideration that occupational and do-:@0.090476:0.466986:0.480971:0.466986:0.480971:0.451204:0.090476:0.451204:0.006290:0.010175:0.007439:0.002873:0.009071:0.010024:0.006350:0.002873:0.009071:0.004974:0.009752:0.006350:0.009631:0.009752:0.009071:0.005715:0.002873:0.010205:0.009676:0.004400:0.010175:0.004974:0.002873:0.009752:0.009071:0.006335:0.004974:0.009071:0.010175:0.004974:0.006335:0.009752:0.009631:0.009631:0.009041:0.010160:0.010175:0.004974:0.002873:0.009752:0.009071:0.010175:0.002873:0.006350:0.010175:0.009071:0.010205:0.006335:0.010205:0.009752:0.005020
mestic exposure to toxic particles in host-susceptible non-:@0.076189:0.481095:0.480956:0.481095:0.480956:0.465312:0.076189:0.465312:0.014030:0.009676:0.005715:0.004974:0.002873:0.009631:0.003296:0.009676:0.007106:0.010160:0.009752:0.005715:0.009041:0.004400:0.009676:0.003296:0.004974:0.009752:0.003296:0.004974:0.009752:0.007106:0.002873:0.009631:0.003296:0.010160:0.010175:0.004400:0.004974:0.002873:0.009631:0.002873:0.009676:0.005715:0.003296:0.002873:0.009071:0.003296:0.009071:0.009752:0.005715:0.004974:0.004868:0.005715:0.009041:0.005715:0.009631:0.009676:0.010160:0.004974:0.002873:0.010160:0.002873:0.009676:0.003296:0.009071:0.009752:0.009071:0.005020
smokers can also cause COpD (about 25-45% of COpD :@0.076189:0.495204:0.485083:0.495204:0.485083:0.479421:0.076189:0.479421:0.005715:0.014030:0.009752:0.007439:0.009676:0.004400:0.005715:0.005367:0.009631:0.010175:0.009071:0.005367:0.010175:0.002873:0.005715:0.009752:0.005367:0.009631:0.010175:0.009041:0.005715:0.009676:0.005367:0.012141:0.012987:0.008799:0.011097:0.005367:0.005428:0.010175:0.010160:0.009752:0.009041:0.004974:0.005367:0.008225:0.008225:0.004868:0.008225:0.008225:0.011566:0.005367:0.009752:0.004596:0.005367:0.012141:0.012987:0.008799:0.011249:0.004188
patients are non-smokers), as well as the increased risk :@0.076189:0.509312:0.485159:0.509312:0.485159:0.493529:0.076189:0.493529:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.006078:0.010175:0.004400:0.009676:0.006078:0.009071:0.009752:0.009071:0.004868:0.005715:0.014030:0.009752:0.007439:0.009676:0.004400:0.005715:0.005428:0.004037:0.006078:0.010175:0.005715:0.006078:0.012413:0.009676:0.002873:0.002873:0.006078:0.010175:0.005715:0.006078:0.004974:0.009071:0.009676:0.006078:0.002873:0.009071:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.010205:0.006078:0.004400:0.002873:0.005715:0.007590:0.004188
of COpD amongst immunocompromised patients, the :@0.076189:0.523421:0.485159:0.523421:0.485159:0.507638:0.076189:0.507638:0.009752:0.004596:0.007423:0.012141:0.012987:0.008799:0.011097:0.007423:0.010175:0.014030:0.009752:0.009071:0.010024:0.005715:0.004974:0.007423:0.002873:0.014030:0.014030:0.009041:0.009071:0.009752:0.009631:0.009752:0.014030:0.010160:0.004400:0.009752:0.014030:0.002873:0.005715:0.009676:0.010205:0.007423:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.004037:0.007423:0.004974:0.009071:0.009827:0.004188
burden  of  this  disease  is  much  higher  than  previously :@0.076189:0.537529:0.485098:0.537529:0.485098:0.521746:0.076189:0.521746:0.010160:0.009041:0.004400:0.010205:0.009676:0.009071:0.004188:0.003508:0.009752:0.004596:0.004188:0.003508:0.004974:0.009071:0.002873:0.005715:0.004188:0.003508:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004188:0.003508:0.002873:0.005715:0.004188:0.003508:0.014030:0.009041:0.009631:0.009071:0.004188:0.003508:0.009071:0.002873:0.010024:0.009071:0.009676:0.004400:0.004188:0.003508:0.004974:0.009071:0.010175:0.009071:0.004188:0.003508:0.010160:0.004400:0.009676:0.008225:0.002873:0.009752:0.009041:0.005715:0.002873:0.008104:0.004188
thought, especially in developing countries. Recurrent :@0.076189:0.551638:0.485174:0.551638:0.485174:0.535855:0.076189:0.535855:0.004974:0.009071:0.009752:0.009041:0.010024:0.009071:0.004974:0.004037:0.007711:0.009676:0.005715:0.010160:0.009676:0.009631:0.002873:0.010175:0.002873:0.002873:0.007953:0.007711:0.002873:0.009071:0.007711:0.010205:0.009676:0.008225:0.009676:0.002873:0.009752:0.010160:0.002873:0.009071:0.010024:0.007711:0.009631:0.009752:0.009041:0.009071:0.004974:0.004400:0.002873:0.009676:0.005715:0.004037:0.007711:0.009026:0.009676:0.009631:0.009041:0.004400:0.004400:0.009676:0.009071:0.005125:0.004188
childhood infections, previous pulmonary tuberculosis, :@0.076189:0.565746:0.485159:0.565746:0.485159:0.549964:0.076189:0.549964:0.009631:0.009071:0.002873:0.002873:0.010205:0.009071:0.009752:0.009752:0.010205:0.008436:0.002873:0.009071:0.004596:0.009676:0.009631:0.004974:0.002873:0.009752:0.009071:0.005715:0.004037:0.008436:0.010160:0.004400:0.009676:0.008225:0.002873:0.009752:0.009041:0.005715:0.008436:0.010160:0.009041:0.002873:0.014030:0.009752:0.009071:0.010175:0.004400:0.007953:0.008436:0.004974:0.009041:0.010160:0.009676:0.004400:0.009631:0.009041:0.002873:0.009752:0.005715:0.002873:0.005715:0.004188:0.004188
chronic asthma, poor intra-uterine growth and malnutri-:@0.076189:0.579855:0.480956:0.579855:0.480956:0.564072:0.076189:0.564072:0.009631:0.009071:0.004400:0.009752:0.009071:0.002873:0.009631:0.004914:0.010175:0.005715:0.004974:0.009071:0.014030:0.010175:0.004037:0.004914:0.010160:0.009752:0.009752:0.004400:0.004914:0.002873:0.009071:0.004974:0.004400:0.010175:0.004868:0.009041:0.004974:0.009676:0.004400:0.002873:0.009071:0.009676:0.004914:0.010024:0.004400:0.009752:0.012413:0.004974:0.009071:0.004914:0.010175:0.009071:0.010205:0.004914:0.014030:0.010175:0.002873:0.009071:0.009041:0.004974:0.004400:0.002873:0.005020
tion have been identified as increasing the risk for COPD.:@0.076189:0.593963:0.476254:0.593963:0.476254:0.578181:0.076189:0.578181:0.004974:0.002873:0.009752:0.009071:0.003266:0.009071:0.010175:0.008225:0.009676:0.003266:0.010160:0.009676:0.009676:0.009071:0.003266:0.002873:0.010205:0.009676:0.009071:0.004974:0.002873:0.003606:0.003606:0.009676:0.010205:0.003266:0.010175:0.005715:0.003266:0.002873:0.009071:0.009631:0.004400:0.009676:0.010175:0.005715:0.002873:0.009071:0.010024:0.003266:0.004974:0.009071:0.009676:0.003266:0.004400:0.002873:0.005715:0.007439:0.003266:0.004596:0.009752:0.004400:0.003266:0.012141:0.012987:0.008799:0.011097:0.004188
2:@0.476092:0.588616:0.480950:0.588616:0.480950:0.579462:0.476092:0.579462:0.004858
 :@0.480952:0.593915:0.485140:0.593915:0.485140:0.578132:0.480952:0.578132:0.004188
In a south African study published in 2003, tuberculosis :@0.076185:0.608023:0.485140:0.608023:0.485140:0.592241:0.076185:0.592241:0.003266:0.009071:0.006214:0.010175:0.006214:0.007378:0.009752:0.009041:0.004974:0.009071:0.006214:0.011037:0.004596:0.004400:0.002873:0.009631:0.010175:0.009071:0.006214:0.005715:0.004974:0.009041:0.010205:0.007953:0.006214:0.010160:0.009041:0.010160:0.002873:0.002873:0.005715:0.009071:0.009676:0.010205:0.006214:0.002873:0.009071:0.006214:0.008225:0.008225:0.008225:0.008225:0.004037:0.006214:0.004974:0.009041:0.010160:0.009676:0.004400:0.009631:0.009041:0.002873:0.009752:0.005715:0.002873:0.005866:0.004188
was found to be a stronger predictor of COpD than to-:@0.076185:0.622132:0.480997:0.622132:0.480997:0.606349:0.076185:0.606349:0.012413:0.010175:0.005715:0.005261:0.004596:0.009752:0.009041:0.009071:0.010205:0.005261:0.004974:0.009752:0.005261:0.010160:0.009676:0.005261:0.010175:0.005261:0.005715:0.004974:0.004400:0.009752:0.009071:0.010024:0.009676:0.004400:0.005261:0.010160:0.004400:0.009676:0.010205:0.002873:0.009631:0.004974:0.009752:0.004400:0.005261:0.009752:0.004596:0.005261:0.012141:0.012987:0.008799:0.011097:0.005261:0.004974:0.009071:0.010175:0.009071:0.005261:0.004974:0.009752:0.005020
bacco smoke, and together with other non-smoking risk :@0.076185:0.636240:0.485155:0.636240:0.485155:0.620458:0.076185:0.620458:0.010160:0.010175:0.009631:0.009631:0.009752:0.004762:0.005715:0.014030:0.009752:0.007439:0.009676:0.004037:0.004762:0.010175:0.009071:0.010205:0.004762:0.004974:0.009752:0.010024:0.009676:0.004974:0.009071:0.009676:0.004400:0.004762:0.012413:0.002873:0.004974:0.009071:0.004762:0.009752:0.004974:0.009071:0.009676:0.004400:0.004762:0.009071:0.009752:0.009071:0.004868:0.005715:0.014030:0.009752:0.007439:0.002873:0.009071:0.010024:0.004762:0.004400:0.002873:0.005715:0.007590:0.004188
factors, 50% of COpD patients were non-smokers.:@0.076185:0.650349:0.428534:0.650349:0.428534:0.634566:0.076185:0.634566:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.005715:0.004037:0.004037:0.008225:0.008225:0.011566:0.004037:0.009752:0.004596:0.004037:0.012141:0.012987:0.008799:0.011097:0.004037:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.004037:0.012413:0.009676:0.004400:0.009676:0.004037:0.009071:0.009752:0.009071:0.004868:0.005715:0.014030:0.009752:0.007439:0.009676:0.004400:0.005715:0.004188
3:@0.428354:0.645029:0.433212:0.645029:0.433212:0.635875:0.428354:0.635875:0.004858
imPACt On sOCiety:@0.076191:0.683178:0.257283:0.683178:0.257283:0.663013:0.076191:0.663013:0.005174:0.016631:0.010348:0.013674:0.014413:0.007761:0.005174:0.015522:0.013674:0.005174:0.009609:0.015522:0.014413:0.005174:0.009609:0.007761:0.011457
COpD patients often have comorbid illnesses and pre-:@0.076191:0.699059:0.480927:0.699059:0.480927:0.683276:0.076191:0.683276:0.012141:0.012987:0.008799:0.011097:0.006169:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.006169:0.009752:0.004596:0.004974:0.009676:0.009071:0.006169:0.009071:0.010175:0.008225:0.009676:0.006169:0.009631:0.009752:0.014030:0.009752:0.004400:0.010160:0.002873:0.010205:0.006169:0.002873:0.002873:0.002873:0.009071:0.009676:0.005715:0.005715:0.009676:0.005715:0.006169:0.010175:0.009071:0.010205:0.006169:0.010160:0.004400:0.009676:0.005020
sent with repeated exacerbations of their pulmonary dis-:@0.076191:0.713167:0.480988:0.713167:0.480988:0.697385:0.076191:0.697385:0.005715:0.009676:0.009071:0.004974:0.003870:0.012413:0.002873:0.004974:0.009071:0.003870:0.004400:0.009676:0.010160:0.009676:0.010175:0.004974:0.009676:0.010205:0.003870:0.009676:0.007106:0.010175:0.009631:0.009676:0.004400:0.010160:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.003870:0.009752:0.004596:0.003870:0.004974:0.009071:0.009676:0.002873:0.004400:0.003870:0.010160:0.009041:0.002873:0.014030:0.009752:0.009071:0.010175:0.004400:0.007953:0.003870:0.010205:0.002873:0.005715:0.005020
ease. Multiple hospital visits with decreased lung function :@0.076191:0.727276:0.485145:0.727276:0.485145:0.711493:0.076191:0.711493:0.009676:0.010175:0.005715:0.009676:0.004037:0.003492:0.013743:0.009041:0.002873:0.004974:0.002873:0.010160:0.002873:0.009676:0.003492:0.009071:0.009752:0.005715:0.010160:0.002873:0.004974:0.010175:0.002873:0.003492:0.008225:0.002873:0.005715:0.002873:0.004974:0.005715:0.003492:0.012413:0.002873:0.004974:0.009071:0.003492:0.010205:0.009676:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.010205:0.003492:0.002873:0.009041:0.009071:0.010024:0.003492:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009223:0.004188
and intensive care place a huge burden on medical and :@0.076191:0.741385:0.485115:0.741385:0.485115:0.725602:0.076191:0.725602:0.010175:0.009071:0.010205:0.003145:0.002873:0.009071:0.004974:0.009676:0.009071:0.005715:0.002873:0.008225:0.009676:0.003145:0.009631:0.010175:0.004400:0.009676:0.003145:0.010160:0.002873:0.010175:0.009631:0.009676:0.003145:0.010175:0.003145:0.009071:0.009041:0.010024:0.009676:0.003145:0.010160:0.009041:0.004400:0.010205:0.009676:0.009071:0.003145:0.009752:0.009071:0.003145:0.014030:0.009676:0.010205:0.002873:0.009631:0.010175:0.002873:0.003145:0.010175:0.009071:0.010357:0.004188
social resources. In a 2006 large cohort study, the three-:@0.076191:0.755493:0.480988:0.755493:0.480988:0.739710:0.076191:0.739710:0.005715:0.009752:0.009631:0.002873:0.010175:0.002873:0.004793:0.004400:0.009676:0.005715:0.009752:0.009041:0.004400:0.009631:0.009676:0.005715:0.004037:0.004793:0.003266:0.009071:0.004793:0.010175:0.004793:0.008225:0.008225:0.008225:0.008225:0.004793:0.002873:0.010175:0.004400:0.010024:0.009676:0.004793:0.009631:0.009752:0.009071:0.009752:0.004400:0.004974:0.004793:0.005715:0.004974:0.009041:0.010205:0.007953:0.004037:0.004793:0.004974:0.009071:0.009676:0.004793:0.004974:0.009071:0.004400:0.009676:0.009676:0.005020
year mortality rate was 47% post hospital admission, and :@0.076191:0.769602:0.485085:0.769602:0.485085:0.753819:0.076191:0.753819:0.007953:0.009676:0.010175:0.004400:0.004339:0.014030:0.009752:0.004400:0.004974:0.010175:0.002873:0.002873:0.004974:0.007953:0.004339:0.004400:0.010175:0.004974:0.009676:0.004339:0.012413:0.010175:0.005715:0.004339:0.008225:0.008225:0.011566:0.004339:0.010160:0.009752:0.005715:0.004974:0.004339:0.009071:0.009752:0.005715:0.010160:0.002873:0.004974:0.010175:0.002873:0.004339:0.010175:0.010205:0.014030:0.002873:0.005715:0.005715:0.002873:0.009752:0.009071:0.004037:0.004339:0.010175:0.009071:0.010357:0.004188
the average cost per admission was 6 725 Euros.:@0.076191:0.783710:0.421524:0.783710:0.421524:0.767928:0.076191:0.767928:0.004974:0.009071:0.009676:0.004037:0.010175:0.008225:0.009676:0.004400:0.010175:0.010024:0.009676:0.004037:0.009631:0.009752:0.005715:0.004974:0.004037:0.010160:0.009676:0.004400:0.004037:0.010175:0.010205:0.014030:0.002873:0.005715:0.005715:0.002873:0.009752:0.009071:0.004037:0.012413:0.010175:0.005715:0.004037:0.008225:0.004037:0.008225:0.008225:0.008225:0.004037:0.007953:0.009041:0.004400:0.009752:0.005715:0.004188
4:@0.421363:0.778379:0.426221:0.778379:0.426221:0.769225:0.421363:0.769225:0.004858
PAtHOPHysiOlOGy Of COPD:@0.076191:0.816528:0.339329:0.816528:0.339329:0.796363:0.076191:0.796363:0.010348:0.013674:0.007761:0.012566:0.015522:0.010348:0.012566:0.011457:0.009609:0.005174:0.015522:0.008131:0.015522:0.015522:0.011457:0.005174:0.015522:0.008870:0.005174:0.014413:0.015522:0.010348:0.012935
The inhalation of noxious particles together with the ge-:@0.076191:0.832409:0.480973:0.832409:0.480973:0.816627:0.076191:0.816627:0.006441:0.009223:0.009827:0.004143:0.003024:0.009223:0.009223:0.010326:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004143:0.009903:0.004747:0.004143:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.004143:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005866:0.004143:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.004127:0.012564:0.003024:0.005125:0.009223:0.004143:0.005125:0.009223:0.009827:0.004143:0.010175:0.009827:0.005020
netic response of the host results in lung inflammation. :@0.076191:0.846518:0.485130:0.846518:0.485130:0.830735:0.076191:0.830735:0.009223:0.009827:0.005125:0.003024:0.009782:0.005760:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.005760:0.009903:0.004747:0.005760:0.005125:0.009223:0.009827:0.005760:0.009223:0.009903:0.005866:0.005125:0.005760:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.005760:0.003024:0.009223:0.005760:0.003024:0.009192:0.009223:0.010175:0.005760:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
The resultant damage and fibrosis caused by the imbal:@0.076191:0.860626:0.475923:0.860626:0.475923:0.844844:0.076191:0.844844:0.006441:0.009223:0.009827:0.003886:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.010326:0.009223:0.005125:0.003901:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.003901:0.010326:0.009223:0.010357:0.003901:0.003681:0.003681:0.010311:0.004551:0.009903:0.005866:0.003024:0.005866:0.003901:0.009782:0.010326:0.009192:0.005866:0.009827:0.010357:0.003901:0.010311:0.008104:0.003901:0.005125:0.009223:0.009827:0.003901:0.003024:0.014182:0.010311:0.010326:0.003024
-:@0.475938:0.860626:0.480957:0.860626:0.480957:0.844844:0.475938:0.844844:0.005020
ance between oxidative stress and protease-antipro-:@0.076191:0.874735:0.480957:0.874735:0.480957:0.858952:0.076191:0.858952:0.010326:0.009223:0.009782:0.009827:0.007287:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.007287:0.009903:0.007257:0.003024:0.010357:0.010326:0.005125:0.003024:0.008376:0.009827:0.007287:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.007287:0.010326:0.009223:0.010357:0.007287:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.005020:0.010326:0.009223:0.005125:0.003024:0.010311:0.004551:0.009903:0.005020
tease  imbalance  result  in  fibrosis  and  damage  to  the :@0.076191:0.888843:0.485130:0.888843:0.485130:0.873061:0.076191:0.873061:0.005125:0.009827:0.010326:0.005866:0.009827:0.004188:0.002404:0.003024:0.014182:0.010311:0.010326:0.003024:0.010326:0.009223:0.009782:0.009827:0.004188:0.002404:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.004188:0.002404:0.003024:0.009223:0.004188:0.002404:0.003681:0.003681:0.010311:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188:0.002404:0.010326:0.009223:0.010357:0.004188:0.002404:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.004188:0.002404:0.005125:0.009903:0.004188:0.002404:0.005125:0.009223:0.009827:0.004188
parenchyma and small airways. Ultimately, obstruction :@0.076191:0.902952:0.485145:0.902952:0.485145:0.887169:0.076191:0.887169:0.010311:0.010326:0.004551:0.009827:0.009223:0.009782:0.009223:0.008104:0.014182:0.010326:0.005156:0.010326:0.009223:0.010357:0.005156:0.005866:0.014182:0.010326:0.003024:0.003024:0.005156:0.010326:0.003024:0.004551:0.012564:0.010326:0.008104:0.005866:0.004188:0.005156:0.009903:0.003024:0.005125:0.003024:0.014182:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.005156:0.009903:0.010311:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
results from the loss of alveolar attachment and support :@0.076191:0.917060:0.485130:0.917060:0.485130:0.901278:0.076191:0.901278:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.003961:0.004747:0.004551:0.009903:0.014182:0.003946:0.005125:0.009223:0.009827:0.003946:0.003024:0.009903:0.005866:0.005866:0.003961:0.009903:0.004747:0.003961:0.010326:0.003024:0.008376:0.009827:0.009903:0.003024:0.010326:0.004551:0.003961:0.010326:0.005125:0.005125:0.010326:0.009782:0.009223:0.014182:0.009827:0.009223:0.005125:0.003946:0.010326:0.009223:0.010357:0.003961:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.004188
in the small airways – airways collapse prematurely on :@0.076191:0.931169:0.485145:0.931169:0.485145:0.915386:0.076191:0.915386:0.003024:0.009223:0.005579:0.005125:0.009223:0.009827:0.005564:0.005866:0.014182:0.010326:0.003024:0.003024:0.005579:0.010326:0.003024:0.004551:0.012564:0.010326:0.008104:0.005866:0.005579:0.007560:0.005579:0.010326:0.003024:0.004551:0.012564:0.010326:0.008104:0.005881:0.005579:0.009782:0.009903:0.003024:0.003024:0.010326:0.010311:0.005866:0.009827:0.005579:0.010311:0.004551:0.009827:0.014182:0.010326:0.005125:0.009192:0.004551:0.009827:0.003024:0.008104:0.005579:0.009903:0.009223:0.004188
expiration before alveolar gas-emptying (see Figure 1). :@0.076191:0.945405:0.476830:0.945405:0.476830:0.929622:0.076191:0.929622:0.009827:0.007257:0.010311:0.003024:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.003447:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.003432:0.010326:0.003024:0.008376:0.009827:0.009903:0.003024:0.010326:0.004551:0.003447:0.010175:0.010326:0.005866:0.005020:0.009827:0.014182:0.010311:0.005125:0.008104:0.003024:0.009223:0.010175:0.003447:0.005579:0.005866:0.009827:0.009827:0.003447:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.003432:0.008376:0.005579:0.004188:0.004188
1:@0.476092:0.940064:0.480950:0.940064:0.480950:0.930910:0.476092:0.930910:0.004858
Neutrophils, alveolar macrophages and lymphocytes :@0.533333:0.168568:0.928000:0.168568:0.928000:0.152785:0.533333:0.152785:0.011188:0.009827:0.009192:0.005125:0.004551:0.009903:0.010311:0.009223:0.003024:0.003024:0.005866:0.004188:0.004460:0.010326:0.003024:0.008376:0.009827:0.009903:0.003024:0.010326:0.004551:0.004475:0.014182:0.010326:0.009782:0.004551:0.009903:0.010311:0.009223:0.010326:0.010175:0.009827:0.005866:0.004460:0.010326:0.009223:0.010357:0.004475:0.003024:0.008104:0.014182:0.010311:0.009223:0.009903:0.009782:0.008104:0.005125:0.009827:0.005866:0.004188
are the predominant inflammatory cell types in response :@0.519045:0.182792:0.928000:0.182792:0.928000:0.167009:0.519045:0.167009:0.010326:0.004551:0.009827:0.003009:0.005125:0.009223:0.009827:0.002994:0.010311:0.004551:0.009827:0.010357:0.009903:0.014182:0.003024:0.009223:0.010326:0.009223:0.005125:0.003009:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.003009:0.009782:0.009827:0.003024:0.003024:0.003009:0.005125:0.008104:0.010311:0.009827:0.005866:0.003009:0.003024:0.009223:0.003009:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.004188
to noxious particle inhalation. In patients with an asth-:@0.519045:0.197016:0.923812:0.197016:0.923812:0.181233:0.519045:0.181233:0.005125:0.009903:0.005775:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.005775:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005791:0.003024:0.009223:0.009223:0.010326:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005775:0.003417:0.009223:0.005791:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005791:0.012564:0.003024:0.005125:0.009223:0.005791:0.010326:0.009223:0.005791:0.010326:0.005866:0.005125:0.009223:0.005020
ma overlap or who are responsive to inhaled cortico-:@0.519045:0.211240:0.923812:0.211240:0.923812:0.195457:0.519045:0.195457:0.014182:0.010326:0.006153:0.009903:0.008376:0.009827:0.004551:0.003024:0.010326:0.010311:0.006153:0.009903:0.004551:0.006138:0.012564:0.009223:0.009903:0.006153:0.010326:0.004551:0.009827:0.006153:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.003024:0.008376:0.009827:0.006153:0.005125:0.009903:0.006153:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.006153:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009888:0.005020
steroids, there is an increased eosinophilic count.  This :@0.519045:0.225464:0.927990:0.225451:0.927990:0.209668:0.519045:0.209681:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.006184:0.005125:0.009223:0.009827:0.004551:0.009827:0.006184:0.003024:0.005866:0.006199:0.010326:0.009223:0.006184:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006184:0.009827:0.009903:0.005866:0.003024:0.009223:0.009903:0.010311:0.009223:0.003024:0.003024:0.003024:0.009782:0.006199:0.009782:0.009903:0.009192:0.009223:0.005125:0.004188:0.004858:0.006184:0.006441:0.009223:0.003024:0.005866:0.111157
5:@0.888205:0.220152:0.893063:0.220152:0.893063:0.210998:0.888205:0.210998:0.004858
COpD phenotype responds to steroids, which inhibit eo-:@0.519050:0.239675:0.923817:0.239675:0.923817:0.223892:0.519050:0.223892:0.012292:0.013138:0.008950:0.011249:0.003734:0.010311:0.009223:0.009827:0.009223:0.009903:0.005125:0.008104:0.010311:0.009827:0.003719:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.005866:0.003734:0.005125:0.009903:0.003734:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.003734:0.012564:0.009223:0.003024:0.009782:0.009223:0.003734:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003734:0.009827:0.009903:0.005020
sinophilic inflammation.:@0.519050:0.253899:0.689698:0.253899:0.689698:0.238116:0.519050:0.238116:0.005866:0.003024:0.009223:0.009903:0.010311:0.009223:0.003024:0.003024:0.003024:0.009782:0.004188:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
DiAGnOstiC issues:@0.519047:0.286861:0.693118:0.286861:0.693118:0.266696:0.519047:0.266696:0.012935:0.005174:0.013674:0.015522:0.013674:0.015522:0.009609:0.007761:0.005174:0.014413:0.005174:0.005174:0.009609:0.009609:0.011826:0.009609:0.009609
A triad of symptoms, risk factors and spirometry enables :@0.519047:0.302860:0.928002:0.302860:0.928002:0.287077:0.519047:0.287077:0.011188:0.004082:0.005125:0.004551:0.003024:0.010326:0.010357:0.004097:0.009903:0.004747:0.004082:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.004097:0.004551:0.003024:0.005866:0.007590:0.004097:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004097:0.010326:0.009223:0.010357:0.004097:0.005866:0.010311:0.003024:0.004551:0.009903:0.014182:0.009827:0.005125:0.004551:0.008104:0.004082:0.009827:0.009223:0.010326:0.010311:0.003024:0.009827:0.005866:0.004188
a diagnosis  of COpD. Dyspnoea, chronic cough and :@0.519047:0.317084:0.928002:0.317084:0.928002:0.301301:0.519047:0.301301:0.010326:0.007076:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.002903:0.009903:0.004747:0.007076:0.012292:0.013138:0.008950:0.011249:0.004188:0.007076:0.011249:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.004188:0.007076:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.007076:0.009782:0.009903:0.009192:0.010175:0.009223:0.007076:0.010326:0.009223:0.010357:0.004188
sputum production are the key symptoms. Look for risk :@0.519047:0.331308:0.927987:0.331308:0.927987:0.315525:0.519047:0.315525:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.005352:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005337:0.010326:0.004551:0.009827:0.005352:0.005125:0.009223:0.009827:0.005352:0.007590:0.009827:0.008104:0.005352:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.005352:0.006985:0.009903:0.009903:0.007590:0.005337:0.004747:0.009903:0.004551:0.005337:0.004551:0.003024:0.005866:0.007590:0.004188
factors, such as smoking, previous tuberculosis, and oc-:@0.519047:0.345532:0.923814:0.345532:0.923814:0.329749:0.519047:0.329749:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.004324:0.005866:0.009192:0.009782:0.009223:0.004339:0.010326:0.005866:0.004339:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188:0.004339:0.010311:0.004551:0.009827:0.008376:0.003024:0.009903:0.009192:0.005866:0.004339:0.005125:0.009192:0.010311:0.009827:0.004551:0.009782:0.009192:0.003024:0.009903:0.005866:0.003024:0.005866:0.004188:0.004339:0.010326:0.009223:0.010357:0.004339:0.009903:0.009782:0.005020
cupational or domestic biomass fuel exposure. A forced :@0.519047:0.359756:0.928002:0.359756:0.928002:0.343973:0.519047:0.343973:0.009782:0.009192:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003492:0.009903:0.004551:0.003492:0.010357:0.009903:0.014182:0.009827:0.005866:0.005125:0.003024:0.009782:0.003492:0.010311:0.003024:0.009903:0.014182:0.010326:0.005866:0.005866:0.003508:0.004747:0.009192:0.009827:0.003024:0.003492:0.009827:0.007257:0.010311:0.009903:0.005866:0.009192:0.004551:0.009827:0.004188:0.003492:0.011188:0.003492:0.004747:0.009903:0.004551:0.009782:0.009827:0.010357:0.004188
expiratory volume in one second (FEV1) to a forced vital :@0.519047:0.373980:0.927987:0.373980:0.927987:0.358197:0.519047:0.358197:0.009827:0.007257:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.003462:0.008376:0.009903:0.003024:0.009192:0.014182:0.009827:0.003462:0.003024:0.009223:0.003462:0.009903:0.009223:0.009827:0.003447:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.003462:0.005579:0.007333:0.008104:0.010614:0.008376:0.005579:0.003462:0.005125:0.009903:0.003462:0.010326:0.003462:0.004747:0.009903:0.004551:0.009782:0.009827:0.010357:0.003447:0.008376:0.003024:0.005125:0.010326:0.003024:0.004188
capacity (FVC) ratio of less than 0.7 predicted for age, :@0.519047:0.388204:0.928002:0.388204:0.928002:0.372421:0.519047:0.372421:0.009782:0.010326:0.010311:0.010326:0.009782:0.003024:0.005125:0.008104:0.004747:0.005579:0.007333:0.010614:0.012292:0.005579:0.004747:0.004551:0.010326:0.005125:0.003024:0.009903:0.004747:0.009903:0.004747:0.004747:0.003024:0.009827:0.005866:0.005866:0.004747:0.005125:0.009223:0.010326:0.009223:0.004747:0.008376:0.004188:0.008376:0.004747:0.010311:0.004551:0.009827:0.010357:0.003024:0.009782:0.005125:0.009827:0.010357:0.004747:0.004747:0.009903:0.004551:0.004732:0.010326:0.010175:0.009827:0.004188:0.004188
sex, weight and ethnicity that does not normalise after :@0.519047:0.402427:0.927987:0.402427:0.927987:0.386645:0.519047:0.386645:0.005866:0.009827:0.007257:0.004188:0.005110:0.012564:0.009827:0.003024:0.010175:0.009223:0.005125:0.005095:0.010326:0.009223:0.010357:0.005110:0.009827:0.005125:0.009223:0.009223:0.003024:0.009782:0.003024:0.005125:0.008104:0.005095:0.005125:0.009223:0.010326:0.005125:0.005095:0.010357:0.009903:0.009827:0.005866:0.005095:0.009223:0.009903:0.005125:0.005095:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005866:0.009827:0.005110:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188
bronchodilation, favours COpD in the context of symp-:@0.519047:0.416651:0.923784:0.416651:0.923784:0.400869:0.519047:0.400869:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.009903:0.010357:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004883:0.004747:0.010326:0.008376:0.009903:0.009192:0.004551:0.005866:0.004899:0.012292:0.013138:0.008950:0.011249:0.004899:0.003024:0.009223:0.004899:0.005125:0.009223:0.009827:0.004899:0.009782:0.009903:0.009223:0.005125:0.009827:0.007257:0.005125:0.004883:0.009903:0.004747:0.004899:0.005866:0.008104:0.014182:0.010311:0.005020
toms and risk factors.:@0.519047:0.430875:0.672112:0.430875:0.672112:0.415093:0.519047:0.415093:0.005125:0.009903:0.014182:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.004551:0.003024:0.005866:0.007590:0.004188:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188
1:@0.672098:0.425548:0.676956:0.425548:0.676956:0.416394:0.672098:0.416394:0.004858
Characteristics of the individual symptoms are as follows::@0.533333:0.447634:0.921892:0.447634:0.921892:0.431851:0.533333:0.431851:0.011838:0.008769:0.009873:0.004097:0.009873:0.009328:0.004672:0.009374:0.004097:0.002570:0.005413:0.004672:0.002570:0.009328:0.005413:0.003734:0.009449:0.004294:0.003734:0.004672:0.008769:0.009374:0.003734:0.002570:0.008769:0.009903:0.002570:0.007922:0.002570:0.009903:0.008739:0.009873:0.002570:0.003734:0.005413:0.007650:0.013728:0.009858:0.004672:0.009449:0.013728:0.005413:0.003734:0.009873:0.004097:0.009374:0.003734:0.009873:0.005413:0.003734:0.004294:0.009449:0.002570:0.002570:0.009449:0.012110:0.005413:0.004188
•  The  onset  of  dyspnoea  is  gradual,  persistent  and :@0.519045:0.461858:0.927985:0.461858:0.927985:0.446075:0.519045:0.446075:0.009162:0.004188:0.006804:0.006441:0.009223:0.009827:0.004188:0.004505:0.009903:0.009223:0.005866:0.009827:0.005125:0.004188:0.004505:0.009903:0.004747:0.004188:0.004505:0.010357:0.008104:0.005866:0.010311:0.009223:0.009903:0.009827:0.010326:0.004188:0.004521:0.003024:0.005866:0.004188:0.004521:0.010175:0.004551:0.010326:0.010357:0.009192:0.010326:0.003024:0.004188:0.004188:0.004521:0.010311:0.009827:0.004551:0.005866:0.003024:0.005866:0.005125:0.009827:0.009223:0.005125:0.004188:0.004521:0.010326:0.009223:0.010357:0.004188
worse with exercise.:@0.539199:0.476082:0.684372:0.476082:0.684372:0.460299:0.539199:0.460299:0.012564:0.009903:0.004551:0.005866:0.009827:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.004188
•  The cough may be productive and intermittent in up :@0.519045:0.490306:0.928000:0.490306:0.928000:0.474523:0.519045:0.474523:0.009162:0.004188:0.006804:0.006441:0.009223:0.009827:0.004067:0.009782:0.009903:0.009192:0.010175:0.009223:0.004067:0.014182:0.010326:0.008104:0.004082:0.010311:0.009827:0.004082:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.003024:0.008376:0.009827:0.004082:0.010326:0.009223:0.010357:0.004082:0.003024:0.009223:0.005125:0.009827:0.004551:0.014182:0.003024:0.005125:0.005125:0.009827:0.009223:0.005125:0.004067:0.003024:0.009223:0.004082:0.009192:0.010311:0.004188
to 30% of patients with associated wheezing.:@0.539199:0.504530:0.866118:0.504530:0.866118:0.488747:0.539199:0.488747:0.005125:0.009903:0.004188:0.008376:0.008376:0.011717:0.004188:0.009903:0.004747:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.012564:0.009223:0.009827:0.009827:0.006426:0.003024:0.009223:0.010175:0.004188
The former definition of cough-productive sputum for :@0.533333:0.518754:0.928000:0.518754:0.928000:0.502971:0.533333:0.502971:0.006441:0.009223:0.009827:0.004778:0.004747:0.009903:0.004551:0.014182:0.009827:0.004551:0.004778:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004778:0.009903:0.004747:0.004793:0.009782:0.009903:0.009192:0.010175:0.009223:0.005020:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.003024:0.008376:0.009827:0.004778:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.004793:0.004747:0.009903:0.004551:0.004188
three  or more consecutive months  over two years for :@0.519045:0.532978:0.928000:0.532978:0.928000:0.517195:0.519045:0.517195:0.005125:0.009223:0.004551:0.009827:0.009827:0.004188:0.002268:0.009903:0.004551:0.006471:0.014182:0.009903:0.004551:0.009827:0.006456:0.009782:0.009903:0.009223:0.005866:0.009827:0.009782:0.009192:0.005125:0.003024:0.008376:0.009827:0.006471:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.002268:0.009903:0.008376:0.009827:0.004551:0.006471:0.005125:0.012564:0.009903:0.006471:0.008104:0.009827:0.010326:0.004551:0.005866:0.006471:0.004747:0.009903:0.004551:0.004188
chronic bronchitis is difficult to use. The reasons are that :@0.519045:0.547202:0.928000:0.547202:0.928000:0.531419:0.519045:0.531419:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004218:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.003024:0.005125:0.003024:0.005866:0.004233:0.003024:0.005866:0.004233:0.010357:0.003024:0.004747:0.003681:0.003681:0.009782:0.009192:0.003024:0.005125:0.004233:0.005125:0.009903:0.004233:0.009192:0.005866:0.009827:0.004188:0.004233:0.006441:0.009223:0.009827:0.004233:0.004551:0.009827:0.010326:0.005866:0.009903:0.009223:0.005866:0.004233:0.010326:0.004551:0.009827:0.004233:0.005125:0.009223:0.010326:0.005125:0.004188
patients often swallow sputum, underlying bronchiecta-:@0.519045:0.561426:0.923812:0.561426:0.923812:0.545643:0.519045:0.545643:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003795:0.009903:0.004747:0.005125:0.009827:0.009223:0.003795:0.005866:0.012564:0.010326:0.003024:0.003024:0.009903:0.012564:0.003810:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.004188:0.003795:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.003795:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.003024:0.009827:0.009782:0.005125:0.010326:0.005020
sis may be present, and flare-ups of COPD may produce :@0.519045:0.575649:0.928015:0.575649:0.928015:0.559867:0.519045:0.559867:0.005866:0.003024:0.005866:0.003251:0.014182:0.010326:0.008104:0.003251:0.010311:0.009827:0.003235:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188:0.003235:0.010326:0.009223:0.010357:0.003251:0.003666:0.003666:0.010326:0.004551:0.009827:0.005020:0.009192:0.010311:0.005866:0.003251:0.009903:0.004747:0.003235:0.012292:0.013138:0.008950:0.011249:0.003251:0.014182:0.010326:0.008104:0.003251:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.004188
an  increase  in  sputum  volume.   COpD  patients  who :@0.519045:0.589873:0.927982:0.589842:0.927982:0.574059:0.519045:0.574091:0.010326:0.009223:0.004188:0.003946:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004188:0.003946:0.003024:0.009223:0.004188:0.003946:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.004188:0.003946:0.008376:0.009903:0.003024:0.009192:0.014182:0.009827:0.004188:0.004880:0.004188:0.003946:0.012292:0.013138:0.008950:0.011249:0.004188:0.003946:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.003946:0.012564:0.009223:0.009903:-0.366014
1:@0.758385:0.584543:0.763243:0.584543:0.763243:0.575389:0.758385:0.575389:0.004858
do  not  fit  the  chronic  bronchitis  profile  will,  therefore, :@0.519042:0.604066:0.928012:0.604066:0.928012:0.588283:0.519042:0.588283:0.010357:0.009903:0.004188:0.002752:0.009223:0.009903:0.005125:0.004188:0.002752:0.003681:0.003681:0.005125:0.004188:0.002752:0.005125:0.009223:0.009827:0.004188:0.002752:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188:0.002752:0.010311:0.004551:0.009903:0.009223:0.009767:0.009223:0.003024:0.005125:0.003024:0.005866:0.004188:0.002752:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188:0.002752:0.012564:0.003024:0.003024:0.003024:0.004188:0.004188:0.002767:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.004188
go undiagnosed either because they do not produce :@0.519042:0.618290:0.927997:0.618290:0.927997:0.602507:0.519042:0.602507:0.010175:0.009903:0.005685:0.009192:0.009223:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.009827:0.010357:0.005685:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.005685:0.010311:0.009827:0.009782:0.010326:0.009192:0.005866:0.009827:0.005685:0.005125:0.009223:0.009827:0.008104:0.005685:0.010357:0.009903:0.005685:0.009223:0.009903:0.005125:0.005685:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.004188
enough sputum or they produce too much sputum and :@0.519042:0.632514:0.927982:0.632514:0.927982:0.616731:0.519042:0.616731:0.009827:0.009223:0.009903:0.009192:0.010175:0.009223:0.003946:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.003961:0.009903:0.004551:0.003946:0.005125:0.009223:0.009827:0.008104:0.003946:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.003946:0.005125:0.009903:0.009903:0.003946:0.014182:0.009192:0.009782:0.009223:0.003946:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.003961:0.010326:0.009223:0.010357:0.004188
are consequently diagnosed as having bronchiectasis.:@0.519042:0.646738:0.919712:0.646738:0.919712:0.630955:0.519042:0.630955:0.010326:0.004551:0.009827:0.004188:0.009782:0.009903:0.009223:0.005866:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.009827:0.010357:0.004188:0.010326:0.005866:0.004188:0.009223:0.010326:0.008376:0.003024:0.009223:0.010175:0.004188:0.010311:0.004551:0.009903:0.009223:0.009782:0.009223:0.003024:0.009827:0.009782:0.005125:0.010326:0.005866:0.003024:0.005866:0.004188
Wheezing  may be heard  and be associated with :@0.533330:0.660962:0.927997:0.660962:0.927997:0.645179:0.533330:0.645179:0.014514:0.009223:0.009827:0.009827:0.006426:0.003024:0.009223:0.010175:0.004188:0.004490:0.014182:0.010326:0.008104:0.008693:0.010311:0.009827:0.008693:0.009223:0.009827:0.010326:0.004551:0.010357:0.004188:0.004490:0.010326:0.009223:0.010357:0.008693:0.010311:0.009827:0.008693:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.008693:0.012564:0.003024:0.005125:0.009223:0.004188
chest tightness, such as asthma. The periodicity of symp-:@0.519042:0.675186:0.923779:0.675186:0.923779:0.659403:0.519042:0.659403:0.009782:0.009223:0.009827:0.005866:0.005125:0.003387:0.005125:0.003024:0.010175:0.009223:0.005125:0.009223:0.009827:0.005866:0.005866:0.004188:0.003387:0.005866:0.009192:0.009782:0.009223:0.003387:0.010326:0.005866:0.003402:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004188:0.003387:0.006441:0.009223:0.009827:0.003387:0.010311:0.009827:0.004551:0.003024:0.009903:0.010357:0.003024:0.009782:0.003024:0.005125:0.008104:0.003402:0.009903:0.004747:0.003387:0.005866:0.008104:0.014182:0.010311:0.005020
toms with recovery, the absence of occupational or do-:@0.519042:0.689410:0.923779:0.689410:0.923779:0.673627:0.519042:0.673627:0.005125:0.009903:0.014182:0.005866:0.003372:0.012564:0.003024:0.005125:0.009223:0.003372:0.004551:0.009827:0.009782:0.009903:0.008376:0.009827:0.004551:0.008104:0.004188:0.003372:0.005125:0.009223:0.009827:0.003372:0.010326:0.010311:0.005866:0.009827:0.009223:0.009782:0.009827:0.003372:0.009903:0.004747:0.003372:0.009903:0.009782:0.009782:0.009192:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003372:0.009903:0.004551:0.003372:0.010357:0.009903:0.005020
mestic noxious particle inhalation and smoking history, :@0.519042:0.703634:0.928027:0.703634:0.928027:0.687851:0.519042:0.687851:0.014182:0.009827:0.005866:0.005125:0.003024:0.009782:0.005730:0.009223:0.009903:0.007257:0.003024:0.009903:0.009192:0.005866:0.005730:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005730:0.003024:0.009223:0.009223:0.010326:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005730:0.010326:0.009223:0.010357:0.005730:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.005730:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.004188
together  with  either  a  history  of  childhood  symptoms :@0.519042:0.717858:0.927967:0.717858:0.927967:0.702075:0.519042:0.702075:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.004188:0.002994:0.012564:0.003024:0.005125:0.009223:0.004188:0.003009:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004188:0.003009:0.010326:0.004188:0.003009:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.003009:0.009903:0.004747:0.004188:0.003009:0.009782:0.009223:0.003024:0.003024:0.010357:0.009223:0.009903:0.009903:0.010357:0.004188:0.003009:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188
or sudden onset of symptoms later in life, help to distin-:@0.519042:0.732082:0.923794:0.732082:0.923794:0.716299:0.519042:0.716299:0.009903:0.004551:0.004838:0.005866:0.009192:0.010357:0.010357:0.009827:0.009223:0.004838:0.009903:0.009223:0.005866:0.009827:0.005125:0.004838:0.009903:0.004747:0.004838:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004838:0.003024:0.010326:0.005125:0.009827:0.004551:0.004838:0.003024:0.009223:0.004838:0.003024:0.003024:0.004747:0.009827:0.004188:0.004838:0.009223:0.009827:0.003024:0.010311:0.004838:0.005125:0.009903:0.004838:0.010357:0.003024:0.005866:0.005125:0.003024:0.009223:0.005020
guish asthma from COpD. Wheezing is not diagnostic of :@0.519042:0.746306:0.927982:0.746306:0.927982:0.730523:0.519042:0.730523:0.010175:0.009192:0.003024:0.005866:0.009223:0.004022:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004022:0.004747:0.004551:0.009903:0.014182:0.004022:0.012292:0.013138:0.008950:0.011249:0.004188:0.004022:0.014514:0.009223:0.009827:0.009827:0.006426:0.003024:0.009223:0.010175:0.004022:0.003024:0.005866:0.004037:0.009223:0.009903:0.005125:0.004022:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.004022:0.009903:0.004747:0.004188
COpD, neither is it diagnostic of asthma.:@0.519042:0.760530:0.812518:0.760530:0.812518:0.744747:0.519042:0.744747:0.012292:0.013138:0.008950:0.011249:0.004188:0.004188:0.009223:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004188:0.003024:0.005866:0.004188:0.003024:0.005125:0.004188:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.005125:0.003024:0.009782:0.004188:0.009903:0.004747:0.004188:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004188
1 :@0.812503:0.755193:0.819790:0.755193:0.819790:0.746039:0.812503:0.746039:0.004858:0.002429
The literature is currently debating the asthma COpD :@0.533333:0.774713:0.928000:0.774713:0.928000:0.758930:0.533333:0.758930:0.006441:0.009223:0.009827:0.004989:0.003024:0.003024:0.005125:0.009827:0.004551:0.010326:0.005125:0.009192:0.004551:0.009827:0.004989:0.003024:0.005866:0.005004:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004974:0.010357:0.009827:0.010311:0.010326:0.005125:0.003024:0.009223:0.010175:0.004989:0.005125:0.009223:0.009827:0.004989:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004989:0.012292:0.013138:0.008950:0.011249:0.004188
overlap (ACO); is this one  disease entity  or  two  dis-:@0.519045:0.788937:0.923797:0.788937:0.923797:0.773154:0.519045:0.773154:0.009903:0.008376:0.009827:0.004551:0.003024:0.010326:0.010311:0.008179:0.005579:0.011188:0.012292:0.013138:0.005579:0.004188:0.008179:0.003024:0.005866:0.008179:0.005125:0.009223:0.003024:0.005866:0.008179:0.009903:0.009223:0.009827:0.004188:0.003976:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.008179:0.009827:0.009223:0.005125:0.003024:0.005125:0.008104:0.004188:0.003976:0.009903:0.004551:0.004188:0.003976:0.005125:0.012564:0.009903:0.004188:0.003976:0.010357:0.003024:0.005866:0.005020
eases?  Asthmatics  who  smoke  can  develop  COPD, :@0.519045:0.803161:0.928000:0.803161:0.928000:0.787378:0.519045:0.787378:0.009827:0.010326:0.005866:0.009827:0.005866:0.008935:0.004188:0.004914:0.011188:0.005866:0.005125:0.009223:0.014182:0.010326:0.005125:0.003024:0.009782:0.005866:0.004188:0.004914:0.012564:0.009223:0.009903:0.004188:0.004899:0.005866:0.014182:0.009903:0.007590:0.009827:0.004188:0.004899:0.009782:0.010326:0.009223:0.004188:0.004914:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.004188:0.004914:0.012292:0.013138:0.008950:0.011249:0.004188:0.004188
patients with COpD can develop late-onset asthma. :@0.519045:0.817385:0.927985:0.817385:0.927985:0.801602:0.519045:0.801602:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.007817:0.012564:0.003024:0.005125:0.009223:0.007817:0.012292:0.013138:0.008950:0.011249:0.007817:0.009782:0.010326:0.009223:0.007817:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.007817:0.003024:0.010326:0.005125:0.009827:0.005020:0.009903:0.009223:0.005866:0.009827:0.005125:0.007817:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.004188:0.004188
Late-onset, asthma-like symptoms in a non-smoker who :@0.519045:0.831609:0.928000:0.831609:0.928000:0.815826:0.519045:0.815826:0.006985:0.010326:0.005125:0.009827:0.005020:0.009903:0.009223:0.005866:0.009827:0.005125:0.004188:0.004445:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.005020:0.003024:0.003024:0.007590:0.009827:0.004460:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004460:0.003024:0.009223:0.004460:0.010326:0.004460:0.009223:0.009903:0.009223:0.005020:0.005866:0.014182:0.009903:0.007590:0.009827:0.004551:0.004445:0.012564:0.009223:0.009903:0.004188
may fit the patient profile of COPD may be difficult to :@0.519045:0.845833:0.927970:0.845833:0.927970:0.830050:0.519045:0.830050:0.014182:0.010326:0.008104:0.005685:0.003681:0.003681:0.005125:0.005685:0.005125:0.009223:0.009827:0.005685:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005685:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.005685:0.009903:0.004747:0.005685:0.012292:0.013138:0.008950:0.011249:0.005685:0.014182:0.010326:0.008104:0.005685:0.010311:0.009827:0.005685:0.010357:0.003024:0.004747:0.003681:0.003681:0.009782:0.009192:0.003024:0.005125:0.005685:0.005125:0.009903:0.004188
diagnose as having either asthma or COpD. To aid re-:@0.519045:0.860057:0.923797:0.860057:0.923797:0.844274:0.519045:0.844274:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.009827:0.005458:0.010326:0.005866:0.005473:0.009223:0.010326:0.008376:0.003024:0.009223:0.010175:0.005473:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.005458:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.005458:0.009903:0.004551:0.005458:0.012292:0.013138:0.008950:0.011249:0.004188:0.005458:0.006441:0.009903:0.005458:0.010326:0.003024:0.010357:0.005473:0.004551:0.009827:0.005020
sponsiveness to inhaled corticosteroids in a patient with :@0.519045:0.874281:0.928000:0.874281:0.928000:0.858498:0.519045:0.858498:0.005866:0.010311:0.009903:0.009223:0.005866:0.003024:0.008376:0.009827:0.009223:0.009827:0.005866:0.005866:0.004218:0.005125:0.009903:0.004203:0.003024:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.004218:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004203:0.003024:0.009223:0.004218:0.010326:0.004218:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004218:0.012564:0.003024:0.005125:0.009223:0.004188
COpD or the development of asthma in a patient with :@0.519045:0.888505:0.927955:0.888505:0.927955:0.872722:0.519045:0.872722:0.012292:0.013138:0.008950:0.011249:0.005035:0.009903:0.004551:0.005035:0.005125:0.009223:0.009827:0.005035:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.005035:0.009903:0.004747:0.005035:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.005035:0.003024:0.009223:0.005035:0.010326:0.005035:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005035:0.012564:0.003024:0.005125:0.009223:0.004188
COpD. A blood eosinophil count of >2% in studies have :@0.519045:0.902729:0.928000:0.902729:0.928000:0.886946:0.519045:0.886946:0.012292:0.013138:0.008950:0.011249:0.004188:0.004505:0.011188:0.004505:0.010311:0.003024:0.009903:0.009903:0.010357:0.004505:0.009827:0.009903:0.005866:0.003024:0.009223:0.009903:0.010311:0.009223:0.003024:0.003024:0.004505:0.009782:0.009903:0.009192:0.009223:0.005125:0.004505:0.009903:0.004747:0.004505:0.009162:0.008376:0.011717:0.004505:0.003024:0.009223:0.004505:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004505:0.009223:0.010326:0.008376:0.009827:0.004188
shown  steroid  responsiveness.  Inhaled corticosteroids :@0.519045:0.916953:0.928020:0.916921:0.928020:0.901138:0.519045:0.901170:0.005866:0.009223:0.009903:0.012564:0.009223:0.004188:0.003492:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.004188:0.003492:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.003024:0.008376:0.009827:0.009223:0.009827:0.005866:0.005866:0.004188:0.004873:0.007696:0.003417:0.009223:0.009223:0.010326:0.003024:0.009827:0.010357:0.007696:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:-0.794370
6:@0.741595:0.911622:0.746454:0.911622:0.746454:0.902468:0.741595:0.902468:0.004858
are then used in the control of COpD as a single entity :@0.519050:0.931145:0.928020:0.931145:0.928020:0.915362:0.519050:0.915362:0.010326:0.004551:0.009827:0.005004:0.005125:0.009223:0.009827:0.009223:0.005004:0.009192:0.005866:0.009827:0.010357:0.005020:0.003024:0.009223:0.005020:0.005125:0.009223:0.009827:0.005004:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.005004:0.009903:0.004747:0.005004:0.012292:0.013138:0.008950:0.011249:0.005020:0.010326:0.005866:0.005020:0.010326:0.005020:0.005866:0.003024:0.009223:0.010175:0.003024:0.009827:0.005020:0.009827:0.009223:0.005125:0.003024:0.005125:0.008104:0.004188
or in a case of asthma-COpD overlap.:@0.519050:0.945369:0.797860:0.945369:0.797860:0.929586:0.519050:0.929586:0.009903:0.004551:0.004188:0.003024:0.009223:0.004188:0.010326:0.004188:0.009782:0.010326:0.005866:0.009827:0.004188:0.009903:0.004747:0.004188:0.010326:0.005866:0.005125:0.009223:0.014182:0.010326:0.005020:0.012292:0.013138:0.008950:0.011249:0.004188:0.009903:0.008376:0.009827:0.004551:0.003024:0.010326:0.010311:0.004188